Stay informed and entertained with our collection of news videos, bringing you the latest updates and information. Watch now to stay up-to-date!
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.
Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.
The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.
Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.
April 16, 2026 07:13 ETEli Lilly and Company (LLY) announced positive topline results from the Phase 3 ACHIEVE-4 trial evaluating the efficacy and safety of Foundayo or orforglipron, compared to insulin glargine in adults with type 2 diabetes and obesity or overweight at increased cardiovascular risk. In the trial, Foundayo...
April 10, 2026 01:04 ETTelix Pharmaceuticals Ltd. (TLX, TLX.AX) announced that the U.S. Food and Drug Administration has accepted its resubmitted New Drug Application or NDA for TLX101-Px (Pixclara, Floretyrosine F18 or 18F-FET), an investigational PET agent for the imaging of glioma (brain cancer). Telix Pharma shares...
May 04, 2026 09:29 ETa2 Milk Company Ltd. (ACOPF, A2M.AX), a dairy company, announced a recall of select infant milk formula, manufactured by Synlait Milk Limited and sold only in the United States, citing the presence of cereulide. The recall involves three batches of a2 Platinum USA label infant milk formula, comprising...